Altre lingue DA32 Life Science Tech Acquisition Corp.

Azioni

DALS

US23312M1062

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

DA32 Life Science Tech Acquisition Corp.(NasdaqCM:DALS) dropped from NASDAQ Composite Index	28/07/23
DA32 Life Science Tech Acquisition to Redeem All Shares	21/07/23
DA32 Life Science Tech Acquisition Corp. Announces Redemption of Shares	21/07/23
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
DA32 LIFE SCIENCE TECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	29/03/23
DA32 Life Science Tech Acquisition Corp. Auditor Raises 'Going Concern' Doubt	29/03/23
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	10/11/22
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	15/08/22
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/08/22
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	13/05/22
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Eight Months Ended December 31, 2021	31/03/22
DA32 LIFE SCIENCE TECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	31/03/22
Certain Class B Common Stock of DA32 Life Science Tech Acquisition Corp. are subject to a Lock-Up Agreement Ending on 23-JAN-2022.	23/01/22
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	15/11/21
DA32 LIFE SCIENCE TECH ACQUISITION CORP. : Other Events (form 8-K)	05/08/21
DA32 Life Science Tech Acquisition Corp. : Sponsored by Deerfield, ARCH Venture Partners and Section 32, Announces Closing of $200 Million Initial Public Offering	30/07/21
DA32 LIFE SCIENCE TECH ACQUISITION CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events (form 8-K)	30/07/21
DA32 Life Science Tech Acquisition Corp. Announces Executive Changes	30/07/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue DA32 Life Science Tech Acquisition Corp.

Azioni

DALS

US23312M1062

Altre lingue

Filtri